|
|
Effect of continuous plasma filtration adsorption in the treatment of severe acute pancreatitis |
ZHOU Hengjie LIU Sibo SHU Jiaojie |
The First Ward of the Department of Critical Care Medicine, Dalian Central Hospital, Liaoning Province, Dalian 116000, China |
|
|
Abstract Objective To investigate the effect of continuous plasma filtration adsorption (CPFA) on severe acute pancreatitis and its effects on tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10). Methods A total of 40 patients with severe acute pancreatitis were selected from October 2014 to June 2018 in the Department of Severe Medicine of Dalian Central Hospital. They were divided into control group (n = 20) and treatment group (n = 20) according to the treatment method. The control group was treated with continuous venovenous hemofiltration (CVVH) for 72 hours on the basis of routine treatment, while the treatment group was treated with CPFA on the basis of the control group. The levels of TNF-α, IL-6 and IL-10 in blood were measured before and after treatment for 3 and 7 days. The vital signs, intra-abdominal pressure, acute physiology and chronic health (APACHEⅡ) scores were compared between the two groups before and after treatment, and the organ function was evaluated, adverse reactions and prognosis were observed. Results There was no significant difference in the clinical indexes between the two groups before treatment (P > 0.05). After 3 days of treatment, the heart rate, oxygenation index, intra-abdominal pressure and APACHE Ⅱ scores of the two groups were lower than those before treatment, and the average arterial pressure and white blood cell count were higher than those before treatment (P < 0.05); the heart rate and intra-abdominal pressure of the treatment group were lower than those of the control group, and the average arterial pressure was higher than that of the control group (P < 0.05). After 7 days of treatment, the heart rate, white blood cell count, intra-abdominal pressure and APACHE Ⅱ scores of the two groups were lower than those before treatment, and the average arterial pressure and oxygenation index were higher than those before treatment (P < 0.05); the heart rate, intra-abdominal pressure and APACHE Ⅱ scores of the treatment group were lower than those of the control group, and the average arterial pressure was higher than that of the control group, with significant differences (P < 0.05). There was no significant difference in the levels of TNF-α, IL-6 and IL-10 between the two groups before treatment (P > 0.05). After 3 days of treatment, the levels of pro-inflammatory cytokines TNF-α, IL-6 in the two groups decreased, the levels of TNF-α and IL-6 in the treatment group were lower than those in the control group (P < 0.05), and the levels of anti-inflammatory cytokines IL-10 in both groups were increased (P < 0.05), and the level of IL-10 in the treatment group was higher than that in the control group (P < 0.05). After 7 days of treatment, the levels of pro-inflammatory cytokines in the two groups decreased further, and the treatment group was lower than the control group, the difference was statistically significant (P < 0.05); while the anti-inflammatory cytokine levels were further increased, and the treatment group was higher than the control group, the difference was statistically significant (P < 0.05). The average hospitalization days and the time needed to continue blood purification treatment in the treatment group were significantly shorter than those in the control group (P < 0.05), but there was no significant difference in mortality between the two groups (P > 0.05). Conclusion CPFA can better regulate the levels of cytokines in the blood, thereby improving clinical symptoms, shortening treatment time and treating severe acute pancreatitis.
|
|
|
|
|
[1] Yasuda T,Ueda T,Takeyama Y,et al. Long-term outcome of severe acute pancreatitis [J]. J Hepatobiliary Pancreat Surg,2008,15(4):397-402.
[2] Makhija R,Kingsnorth AN. Cytokine storm in acute pancreatitis [J]. J Hepatobiliary Pancreat Surg,2002,9(4):401-410.
[3] 虞文魁,石佳靓.重症急性胰腺炎血液净化治疗[J].中国实用内科杂志,2016,36(5):365-367.
[4] 罗建宇,王晓源,蒋文芳,等.连续性静脉-静脉血液滤过联合血液灌流治疗急性胰腺炎时机的研究[J].中国血液净化,2016, 15(12):664-668.
[5] 李小涛.血液灌流+连续性静脉血液滤过治疗急性胰腺炎的疗效观察[J].临床合理用药杂志,2016,9(20):98-99.
[6] Hazzard I,Jones S,Quinn T. Coupled plasma haemofiltration filtration in severe sepsis: systematic review and meta-analysis [J]. J R Army Med Corps,2015,1(Suppl 1):i17-i22.
[7] Lankisch PG,Apte M,Banks PA. Acute pancreatitis [J]. Der Internist,2015,386(9988):85-96.
[8] Portelli M,Jones CD. Severe acute pancreatitis:pathogenesis,diagnosis and surgical management [J]. Hepatobiliary Pancreat Dis Int,2017,16(2):155-159.
[9] Malleo G,Mazzon E,Genovese T,et al. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice:a comparison with TNF-alpha genetic deletion [J]. Shock,2007,27(5):542-551.
[10] Ramudo L,Manso MA,Sevillano S,et al. Kinetic study of TNF-α production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bilepancreatic duct obstruction [J]. J Pathol,2005,206(1):9.
[11] Devière J,Le MO,Van Laethem JL,et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography [J]. Gastroenterology,2001,120(2):498-505.
[12] Xu J,Cui Y,Tian X. Early Continuous Veno-Venous Hemofiltration Is Effective in Decreasing Intra-Abdominal Pressure and Serum Interleukin-8 Level in Severe Acute Pancreatitis Patients with Abdominal Compartment Syndrome [J]. Blood Purif,2017,44(4):276-282.
[13] 商惠萍,张昭然,李德天.急性胰腺炎致急性肾损伤及影响肾功能预后的相关因素分析[J].中国血液净化,2017, 16(12):811-815.
[14] Sander A,Armbruster W,Sander B,et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations [J]. Intensive Care Med,1997, 23(8):878-884.
[15] De Vriese AS,Vanholder RC,Pascual M,et al. Can inflammatory cytokines,be removed efficiently by continuous,renal replacement therapies?[J]. Intensive Care Med,1999,25(9):903-910.
[16] De Vriese AS,Colardyn FA,Philippé JJ,et al. Cytokine Removal during Continuous Hemofiltration in Septic Patients [J]. J Am Soc Nephrol,1999,10(4):846-853.
[17] Mao HJ,Yu S,Yu XB,et al. Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome [J]. Int J Artif Organs,2009,32(1):31-38.
[18] Yin SL,Lan C,Pei H,et al. Continuous plasma filtration adsorption in treatment of severe infection-induced multiple organ dysfunction syndrome [J]. J Biol Regul Homeost Agents,2016,30(2):471-476.
[19] 赵黎,陈华茜,刘巍,等.配对血浆滤过吸附在严重脓毒症中的应用研究[J].中国血液净化,2015,14(3):168-172.
[20] Franchi M,Giacalone M,Traupe I,et al. Coupled plasma filtration adsorption improves hemodynamics in septic shock [J]. J Crit Care,2016,33:100-105. |
|
|
|